The company’s stock has fallen with competition intensifying from telehealth providers of GLP-1 drugs.
Source link
2025-04-04
Welcome
The company’s stock has fallen with competition intensifying from telehealth providers of GLP-1 drugs.
Source link
Privacy Policy Designed using Magazine News Byte. Powered by WordPress.